IART · Integra Lifesciences Holdings Q2 FY2026 earnings call record财报电话会记录

“We continue to invest in the pipeline and are confident in our commercial team's ability to drive meaningful growth contributions as the business and portfolio continue to develop.”

“We remain focused on creating long-term value for customers, shareholders, and employees.”

“Our second quarter revenues were $419 million, representing 0.8% growth on a reported basis and 0.7% growth on an organic basis.”

“Gross margin for the quarter was 61.3%, up approximately 60 basis points from 60.7% in the prior year, reflecting efficiencies achieved across manufacturing operations and lower remediation spending.”

“Adjusted EBITDA margin was 18.7%, up approximately 160 basis points versus 17.1% in Q2 2025, reflecting the benefits of the gross margin drivers I just discussed, together with contributions from our recent margin improvement initiatives.”

“For the first half of 2026, operating cash flow increased $35 million compared to 2025, and we remain on track to deliver an approximate $150 million improvement in operating cash flow for the year, driven by EBITDA growth, working capital efficiency and an approximate $60 million reduction in cash expenditures related to EU MDR compliance and Braintree startup costs.”

“As of June 30th, net debt was $1.6 billion and our consolidated total leverage ratio was 4.1x within our current maximum allowable leverage of 5x.”

“Reducing our leverage and continued debt repayment remain our top capital allocation priorities for 2026.”

“For the third quarter, we expect revenues to be in a range of $410 million-$425 million, representing reported growth of 2%-5.7% and organic growth of 1.9%-5.7%.”

“Turning to the full-year 2026, we are reaffirming our organic revenue growth guidance range of 0.8%-3.3%, reflecting our expectation for a second half revenue increase driven by normal seasonality and continued improvement in supply.”

“We are updating our reported revenue outlook to a range of $1.654 billion-$1.695 billion and reported growth of 1.1%-3.7% to reflect the FX impact of a stronger U.S.”

“We have real confidence in the demand for that product from legacy customers as well as new customers.”